Home > Insider Trading > Filing (0001179110-17-008065)

Filing Details

Accession Number:: 0001179110-17-008065
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-26 15:10:52
Reporting Period:: 2017-05-25

Filing Date:: 2017-05-26
Accepted Time:: 2017-05-26 15:10:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371217	Enteromedics Inc	ETRM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1110780	Carl Goldfischer	2800 Patton Road St. Paul MN 55113		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-25	4,571	$4.85	0	No	4	S	Indirect	See footnote (1)
Common Stock	Acquisiton	2017-05-25	97	$4.85	0	No	4	S	Indirect	See footnote note (2)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote (1)
No	4	S	Indirect	See footnote note (2)

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Director Option (Right to Buy)	$50,410.50	2008-03-25	2018-03-24	3	3	Direct
Common Stock	Director Option (Right to Buy)	$12,159.00	2009-05-05	2019-05-05	1	1	Direct
Common Stock	Director Option (Right to Buy)	$2,646.00	2010-05-06	2020-05-06	1	1	Direct
Common Stock	Director Option (Right to Buy)	$2,761.50	2011-05-05	2021-05-05	9	9	Direct
Common Stock	Director Option (Right to Buy)	$2,908.50	2012-05-09	2022-05-09	9	9	Direct
Common Stock	Director Option (Right to Buy)	$924.00	2013-05-08	2023-05-08	9	9	Direct
Common Stock	Director Option (Right to Buy)	$1,932.00	2014-05-07	2024-05-07	23	23	Direct
Common Stock	Director Option (Right to Buy)	$1,176.00	2015-05-06	2025-05-06	23	23	Direct
Common Stock	Director Option (Right to Buy)	$1,176.00	2015-06-06	2025-05-06	23	23	Direct
Common Stock	Director Option (Right to Buy)	$52.50	2016-05-04	2026-05-04	42	42	Direct
Common Stock	Director Option (Right to Buy)	$7.12	2017-02-08	2027-02-08	35,000	35,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-03-24	3	3	Direct
2019-05-05	1	1	Direct
2020-05-06	1	1	Direct
2021-05-05	9	9	Direct
2022-05-09	9	9	Direct
2023-05-08	9	9	Direct
2024-05-07	23	23	Direct
2025-05-06	23	23	Direct
2025-05-06	23	23	Direct
2026-05-04	42	42	Direct
2027-02-08	35,000	35,000	Direct

Footnotes

Represents shares held by Bay City Capital Fund IV, L.P. ("Fund IV"), including the shares held by Dr. Goldfischer; and indirect interests of Bay City Capital LLC ("BCC"), the manager of Bay City Capital Management IV LLC ("Management IV"), and Management IV, the general partner of Fund IV. Dr. Goldfischer is Managing Director of BCC. Dr. Goldfischer, BCC and Management IV each disclaims beneficial ownership in such shares, except to the extent of their pecuniary interest therein.
Represents shares held by Bay City Capital Fund IV Co-Investment Fund, L.P. ("Co-Investment IV"), including the shares held by Dr. Goldfischer; and indirect interests of BCC, the manager of Management IV, and Management IV, the general partner of Co-Investment IV. Dr. Goldfischer, BCC and Management IV each disclaims beneficial ownership in such shares, except to the extent of their pecuniary interest therein.
25% of the shares shall vest immediately, and the remaining shares shall vest 1/36 per month thereafter, as long as the reporting person remains a director of the company.
25% of the shares subject to the option are exercisable immediately. The remaining 75% of the shares subject to the option shall vest in a series of thirty-six (36) successive equal monthly installments upon completion of each month over the three (3) year period measured from the date shown.
Option vests in successive installments of 1/12th per month beginning the date shown.
The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $4.75 to $5.00. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.